Benjamin J. Hindson - Dec 14, 2022 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
President and Chief Scientific Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Benjamin J. Hindson
Stock symbol
TXG
Transactions as of
Dec 14, 2022
Transactions value $
$172,701
Form type
4
Date filed
12/16/2022, 03:46 PM
Previous filing
Nov 23, 2022
Next filing
Feb 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Options Exercise $173K +34.3K +15.74% $5.04* 252K Dec 14, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Stock Option (right to buy) Options Exercise $0 -34.3K -72.54% $0.00 13K Dec 14, 2022 Class A Common Stock 34.3K $5.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All of the shares subject to the option are fully vested and exercisable as of the date hereof.

Remarks:

President and Chief Scientific Officer